Voyageur Pharmaceuticals Ltd. has submitted a notice of work with the BC Ministry of Mines for the removal of 2,000 tonnes of barite in 2023. Upon approval from the BCMM, this sample will be used for testing on a new active pharmaceutical ingredient pilot plant, that is tentatively scheduled to begin construction in 2023. Voyageur will excavate small, 2-metre-wide surface trenches, to remove 1,000 tonnes of barite from the A zone and 1,000 tonnes from the B zone.

This tonnage is expected to allow for a complete testing and modifications to the new barium API pilot plant that the Company plans to construct. Upon completion of this work program, a notice of work for a Small Quarry will be submitted to the BC Ministry of Mines, with plans for full production in 2024. The 2,000 tonnes are expected to be a high-grade sample with low waste.

Voyageur's goal is to extract 1,000 to 1,200 tonnes of high purity barium sulfate from this sample, to be used in barium contrast manufacturing. To put the number in perspective, 1,000 tonnes of pharmaceutical grade barium sulfate, can create: Approximately 111,111,000 bottles of SmoothX smoothie contrast media, or Approximately 3,000,000 bottles of HDX powdered contrast media This is a major step forward to bring the Frances Creek barium sulfate project into production. SGS Canada completed a Preliminary Economic Assessment and assigned a NPV of $344 million with an IRR of 137%, to the Frances Creek project.

By moving this project to production, Voyageur will be able to begin to capitalise on its barium resource. Voyageur's management is designing a new barium API pilot plant, with the goal to reduce the capital required, compared to the SGS PEA, that stated capital required of $36 Million over three years. Voyageur's plan is to build a lower cost production facility, fast track production, process the 2,000 tonnes of barium sulfate and complete full feasibility based on live real time sales of product.

This is expected to allow the Frances Creek project to be valued with a NI 43-101 defined reserve. Voyageur has issued 300,000 stock options with an exercise price of $0.10/share, to Albert Deslauriers,Voyageur's interim CFO.